The study was published in the journal npj Digital Medicine.
Using AI allowed the team to split trial participants into two groups: either slowly or rapidly progressing towards Alzheimer’s disease.
"AI-assisted MRI could potentially detect cancers that humans wouldn’t find otherwise," said the study's lead investigator Felipe Oviedo, Ph.D., a senior research analyst at Microsoft's AI for Good Lab.